CID 112020

10190-69-9

Structural Information

Molecular Formula
C31H23N5O5S3
SMILES
CC1=C(C2=C(C=C1)N=C(S2)C3=CC4=C(C=C3)N=C(S4)C5=CC=C(C=C5)N=NC(C(=O)C)C(=O)NC6=CC=CC=C6)S(=O)(=O)O
InChI
InChI=1S/C31H23N5O5S3/c1-17-8-14-24-27(28(17)44(39,40)41)43-31(34-24)20-11-15-23-25(16-20)42-30(33-23)19-9-12-22(13-10-19)35-36-26(18(2)37)29(38)32-21-6-4-3-5-7-21/h3-16,26H,1-2H3,(H,32,38)(H,39,40,41)
InChIKey
WJFOVRZETXKKMI-UHFFFAOYSA-N
Compound name
2-[2-[4-[(1-anilino-1,3-dioxobutan-2-yl)diazenyl]phenyl]-1,3-benzothiazol-6-yl]-6-methyl-1,3-benzothiazole-7-sulfonic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

641.0861 Da
Monoisotopic Mass

6.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 642.09338 234.5
[M+Na]+ 664.07532 246.5
[M+NH4]+ 659.11992 239.5
[M+K]+ 680.04926 238.8
[M-H]- 640.07882 241.8
[M+Na-2H]- 662.06077 244.5
[M]+ 641.08555 239.5
[M]- 641.08665 239.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.